U.S. FDA adds 7 inspectors to its team in India

10/17/2013 | BioSpectrum Asia

Seven new investigators are joining the U.S. FDA's staff in India, raising the total of the American team assigned to handling regulatory issues tied to Indian generic drugmakers to 19. "Our presence in India allows us to better collaborate with our Indian regulatory counterparts and enables us to leverage our combined resources, harmonize science-based standards and increase regulatory capacity," according to a statement from the agency.

View Full Article in:

BioSpectrum Asia